Moreover, the increased preoperative level of serum soluble interleukin-2 receptor (IL-2R) in patients with colorectal cancer may suggest receptor release by activated inflammatory cells in the tumor milieu [8]. This evidence concerns the gene IL2RA and neoplasm.